Laird Norton Trust Company, LLC In8 Bio, Inc. Transaction History
Laird Norton Trust Company, LLC
- $709 Million
- Q2 2024
A detailed history of Laird Norton Trust Company, LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 42,300 shares of INAB stock, worth $10,998. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,300
Previous 42,300
-0.0%
Holding current value
$10,998
Previous $49,000
28.57%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
7.74MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.13MShares$553,2790.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$370,2130.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$290,7490.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL641KShares$166,6620.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI600KShares$155,9160.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $6.37M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...